<?xml version="1.0" encoding="UTF-8"?>
<p>In this study, we evaluated HIV drug resistance and antiretroviral (ARV) drug use at study entry and the impact of baseline resistance on viral suppression. ARV drug use was assessed using self-reported data on ART and ARV drug testing. ARV drug testing data were used for the main study assessments, since we previously demonstrated that almost half (45.8%) of the index participants who had ARV drugs detected at study entry reported that they were not on ART, and 75% of those who reported that they were on ART did not have ARV drugs detected [
 <xref rid="pone.0223829.ref018" ref-type="bibr">18</xref>]. Findings from this study may help target resources to improve HIV care in these high-risk populations and inform the design of future research studies that include ART for HIV prevention.
</p>
